Physical Therapy Equipment
Physical Therapy Equipment market is segmented by region (country), players, by Type and by Appli ... Read More
1 Study Coverage 1.1 Venous Thromboembolism (VTE) Devices Product Introduction 1.2 Global Venous Thromboembolism (VTE) Devices Outlook 2017 VS 2022 VS 2028 1.2.1 Global Venous Thromboembolism (VTE) Devices Sales in US$ Million for the Year 2017-2028 1.2.2 Global Venous Thromboembolism (VTE) Devices Sales in Volume for the Year 2017-2028 1.3 United States Venous Thromboembolism (VTE) Devices Outlook 2017 VS 2022 VS 2028 1.3.1 United States Venous Thromboembolism (VTE) Devices Sales in US$ Million for the Year 2017-2028 1.3.2 United States Venous Thromboembolism (VTE) Devices Sales in Volume for the Year 2017-2028 1.4 Venous Thromboembolism (VTE) Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Venous Thromboembolism (VTE) Devices in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Venous Thromboembolism (VTE) Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Venous Thromboembolism (VTE) Devices Market Dynamics 1.5.1 Venous Thromboembolism (VTE) Devices Industry Trends 1.5.2 Venous Thromboembolism (VTE) Devices Market Drivers 1.5.3 Venous Thromboembolism (VTE) Devices Market Challenges 1.5.4 Venous Thromboembolism (VTE) Devices Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Venous Thromboembolism (VTE) Devices Market Segment by Type 2.1.1 Deep Vein Thrombosis(DVT) 2.1.2 Pulmonary Embolism(PE) 2.1.3 Others 2.2 Global Venous Thromboembolism (VTE) Devices Market Size by Type 2.2.1 Global Venous Thromboembolism (VTE) Devices Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Venous Thromboembolism (VTE) Devices Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Venous Thromboembolism (VTE) Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Venous Thromboembolism (VTE) Devices Market Size by Type 2.3.1 United States Venous Thromboembolism (VTE) Devices Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Venous Thromboembolism (VTE) Devices Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Venous Thromboembolism (VTE) Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Venous Thromboembolism (VTE) Devices Market Segment by Application 3.1.1 Hospitals 3.1.2 Surgical Centers 3.1.3 Other 3.2 Global Venous Thromboembolism (VTE) Devices Market Size by Application 3.2.1 Global Venous Thromboembolism (VTE) Devices Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Venous Thromboembolism (VTE) Devices Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Venous Thromboembolism (VTE) Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Venous Thromboembolism (VTE) Devices Market Size by Application 3.3.1 United States Venous Thromboembolism (VTE) Devices Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Venous Thromboembolism (VTE) Devices Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Venous Thromboembolism (VTE) Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Venous Thromboembolism (VTE) Devices Competitor Landscape by Company 4.1 Global Venous Thromboembolism (VTE) Devices Market Size by Company 4.1.1 Top Global Venous Thromboembolism (VTE) Devices Manufacturers Ranked by Revenue (2021) 4.1.2 Global Venous Thromboembolism (VTE) Devices Revenue by Manufacturer (2017-2022) 4.1.3 Global Venous Thromboembolism (VTE) Devices Sales by Manufacturer (2017-2022) 4.1.4 Global Venous Thromboembolism (VTE) Devices Price by Manufacturer (2017-2022) 4.2 Global Venous Thromboembolism (VTE) Devices Concentration Ratio (CR) 4.2.1 Venous Thromboembolism (VTE) Devices Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Venous Thromboembolism (VTE) Devices in 2021 4.2.3 Global Venous Thromboembolism (VTE) Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Venous Thromboembolism (VTE) Devices Manufacturing Base Distribution, Product Type 4.3.1 Global Venous Thromboembolism (VTE) Devices Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Venous Thromboembolism (VTE) Devices Product Type 4.3.3 Date of International Manufacturers Enter into Venous Thromboembolism (VTE) Devices Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Venous Thromboembolism (VTE) Devices Market Size by Company 4.5.1 Top Venous Thromboembolism (VTE) Devices Players in United States, Ranked by Revenue (2021) 4.5.2 United States Venous Thromboembolism (VTE) Devices Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Venous Thromboembolism (VTE) Devices Sales by Players (2020, 2021 & 2022) 5 Global Venous Thromboembolism (VTE) Devices Market Size by Region 5.1 Global Venous Thromboembolism (VTE) Devices Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Venous Thromboembolism (VTE) Devices Market Size in Volume by Region (2017-2028) 5.2.1 Global Venous Thromboembolism (VTE) Devices Sales in Volume by Region: 2017-2022 5.2.2 Global Venous Thromboembolism (VTE) Devices Sales in Volume Forecast by Region (2023-2028) 5.3 Global Venous Thromboembolism (VTE) Devices Market Size in Value by Region (2017-2028) 5.3.1 Global Venous Thromboembolism (VTE) Devices Sales in Value by Region: 2017-2022 5.3.2 Global Venous Thromboembolism (VTE) Devices Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Venous Thromboembolism (VTE) Devices Market Size YoY Growth 2017-2028 6.1.2 North America Venous Thromboembolism (VTE) Devices Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Venous Thromboembolism (VTE) Devices Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Venous Thromboembolism (VTE) Devices Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Venous Thromboembolism (VTE) Devices Market Size YoY Growth 2017-2028 6.3.2 Europe Venous Thromboembolism (VTE) Devices Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Venous Thromboembolism (VTE) Devices Market Size YoY Growth 2017-2028 6.4.2 Latin America Venous Thromboembolism (VTE) Devices Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Venous Thromboembolism (VTE) Devices Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Venous Thromboembolism (VTE) Devices Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 ArjoHuntleigh 7.1.1 ArjoHuntleigh Corporation Information 7.1.2 ArjoHuntleigh Description and Business Overview 7.1.3 ArjoHuntleigh Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022) 7.1.4 ArjoHuntleigh Venous Thromboembolism (VTE) Devices Products Offered 7.1.5 ArjoHuntleigh Recent Development 7.2 Armetheon 7.2.1 Armetheon Corporation Information 7.2.2 Armetheon Description and Business Overview 7.2.3 Armetheon Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Armetheon Venous Thromboembolism (VTE) Devices Products Offered 7.2.5 Armetheon Recent Development 7.3 Bayer 7.3.1 Bayer Corporation Information 7.3.2 Bayer Description and Business Overview 7.3.3 Bayer Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Bayer Venous Thromboembolism (VTE) Devices Products Offered 7.3.5 Bayer Recent Development 7.4 Bio Compression Systems 7.4.1 Bio Compression Systems Corporation Information 7.4.2 Bio Compression Systems Description and Business Overview 7.4.3 Bio Compression Systems Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Bio Compression Systems Venous Thromboembolism (VTE) Devices Products Offered 7.4.5 Bio Compression Systems Recent Development 7.5 Boehringer Ingelheim 7.5.1 Boehringer Ingelheim Corporation Information 7.5.2 Boehringer Ingelheim Description and Business Overview 7.5.3 Boehringer Ingelheim Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Boehringer Ingelheim Venous Thromboembolism (VTE) Devices Products Offered 7.5.5 Boehringer Ingelheim Recent Development 7.6 Breg 7.6.1 Breg Corporation Information 7.6.2 Breg Description and Business Overview 7.6.3 Breg Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Breg Venous Thromboembolism (VTE) Devices Products Offered 7.6.5 Breg Recent Development 7.7 Bristol-Myers Squibb 7.7.1 Bristol-Myers Squibb Corporation Information 7.7.2 Bristol-Myers Squibb Description and Business Overview 7.7.3 Bristol-Myers Squibb Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Bristol-Myers Squibb Venous Thromboembolism (VTE) Devices Products Offered 7.7.5 Bristol-Myers Squibb Recent Development 7.8 Cardinal Health 7.8.1 Cardinal Health Corporation Information 7.8.2 Cardinal Health Description and Business Overview 7.8.3 Cardinal Health Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022) 7.8.4 Cardinal Health Venous Thromboembolism (VTE) Devices Products Offered 7.8.5 Cardinal Health Recent Development 7.9 Currie Medical Specialties 7.9.1 Currie Medical Specialties Corporation Information 7.9.2 Currie Medical Specialties Description and Business Overview 7.9.3 Currie Medical Specialties Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022) 7.9.4 Currie Medical Specialties Venous Thromboembolism (VTE) Devices Products Offered 7.9.5 Currie Medical Specialties Recent Development 7.10 Daiichi-Sankyo 7.10.1 Daiichi-Sankyo Corporation Information 7.10.2 Daiichi-Sankyo Description and Business Overview 7.10.3 Daiichi-Sankyo Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022) 7.10.4 Daiichi-Sankyo Venous Thromboembolism (VTE) Devices Products Offered 7.10.5 Daiichi-Sankyo Recent Development 7.11 Devon Medical Products 7.11.1 Devon Medical Products Corporation Information 7.11.2 Devon Medical Products Description and Business Overview 7.11.3 Devon Medical Products Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022) 7.11.4 Devon Medical Products Venous Thromboembolism (VTE) Devices Products Offered 7.11.5 Devon Medical Products Recent Development 7.12 DJO 7.12.1 DJO Corporation Information 7.12.2 DJO Description and Business Overview 7.12.3 DJO Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022) 7.12.4 DJO Products Offered 7.12.5 DJO Recent Development 7.13 Janssen 7.13.1 Janssen Corporation Information 7.13.2 Janssen Description and Business Overview 7.13.3 Janssen Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022) 7.13.4 Janssen Products Offered 7.13.5 Janssen Recent Development 7.14 Mego Afek AC LTD 7.14.1 Mego Afek AC LTD Corporation Information 7.14.2 Mego Afek AC LTD Description and Business Overview 7.14.3 Mego Afek AC LTD Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022) 7.14.4 Mego Afek AC LTD Products Offered 7.14.5 Mego Afek AC LTD Recent Development 7.15 Normatec 7.15.1 Normatec Corporation Information 7.15.2 Normatec Description and Business Overview 7.15.3 Normatec Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022) 7.15.4 Normatec Products Offered 7.15.5 Normatec Recent Development 7.16 Pfizer 7.16.1 Pfizer Corporation Information 7.16.2 Pfizer Description and Business Overview 7.16.3 Pfizer Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022) 7.16.4 Pfizer Products Offered 7.16.5 Pfizer Recent Development 7.17 Portola Pharmaceuticals 7.17.1 Portola Pharmaceuticals Corporation Information 7.17.2 Portola Pharmaceuticals Description and Business Overview 7.17.3 Portola Pharmaceuticals Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022) 7.17.4 Portola Pharmaceuticals Products Offered 7.17.5 Portola Pharmaceuticals Recent Development 7.18 ThermoTek USA 7.18.1 ThermoTek USA Corporation Information 7.18.2 ThermoTek USA Description and Business Overview 7.18.3 ThermoTek USA Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022) 7.18.4 ThermoTek USA Products Offered 7.18.5 ThermoTek USA Recent Development 7.19 Zimmer Biomet 7.19.1 Zimmer Biomet Corporation Information 7.19.2 Zimmer Biomet Description and Business Overview 7.19.3 Zimmer Biomet Venous Thromboembolism (VTE) Devices Sales, Revenue and Gross Margin (2017-2022) 7.19.4 Zimmer Biomet Products Offered 7.19.5 Zimmer Biomet Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Venous Thromboembolism (VTE) Devices Industry Chain Analysis 8.2 Venous Thromboembolism (VTE) Devices Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Venous Thromboembolism (VTE) Devices Distributors 8.3 Venous Thromboembolism (VTE) Devices Production Mode & Process 8.4 Venous Thromboembolism (VTE) Devices Sales and Marketing 8.4.1 Venous Thromboembolism (VTE) Devices Sales Channels 8.4.2 Venous Thromboembolism (VTE) Devices Distributors 8.5 Venous Thromboembolism (VTE) Devices Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
List of Tables Table 1. Venous Thromboembolism (VTE) Devices CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Venous Thromboembolism (VTE) Devices Market Trends Table 3. Venous Thromboembolism (VTE) Devices Market Drivers Table 4. Venous Thromboembolism (VTE) Devices Market Challenges Table 5. Venous Thromboembolism (VTE) Devices Market Restraints Table 6. Global Venous Thromboembolism (VTE) Devices Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Venous Thromboembolism (VTE) Devices Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Venous Thromboembolism (VTE) Devices Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Venous Thromboembolism (VTE) Devices Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Venous Thromboembolism (VTE) Devices Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Venous Thromboembolism (VTE) Devices Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Venous Thromboembolism (VTE) Devices Revenue Share by Manufacturer, 2017-2022 Table 13. Global Venous Thromboembolism (VTE) Devices Sales by Manufacturer, (K Units), 2017-2022 Table 14. Global Venous Thromboembolism (VTE) Devices Sales Share by Manufacturer, 2017-2022 Table 15. Global Venous Thromboembolism (VTE) Devices Price by Manufacturer (2017-2022) & (US$/Unit) Table 16. Global Venous Thromboembolism (VTE) Devices Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Venous Thromboembolism (VTE) Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venous Thromboembolism (VTE) Devices as of 2021) Table 18. Top Players of Venous Thromboembolism (VTE) Devices in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Venous Thromboembolism (VTE) Devices Product Type Table 20. Date of International Manufacturers Enter into Venous Thromboembolism (VTE) Devices Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Venous Thromboembolism (VTE) Devices Players in United States Market, Ranking by Revenue (2021) Table 23. United States Venous Thromboembolism (VTE) Devices Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Venous Thromboembolism (VTE) Devices Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Venous Thromboembolism (VTE) Devices Sales by Players, (K Units), 2020, 2021 & 2022 Table 26. United States Venous Thromboembolism (VTE) Devices Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Venous Thromboembolism (VTE) Devices Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Venous Thromboembolism (VTE) Devices Sales in Volume by Region (2017-2022) & (K Units) Table 29. Global Venous Thromboembolism (VTE) Devices Sales in Volume Forecast by Region (2023-2028) & (K Units) Table 30. Global Venous Thromboembolism (VTE) Devices Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Venous Thromboembolism (VTE) Devices Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Venous Thromboembolism (VTE) Devices Sales in Volume by Country (2017-2028) & (K Units) Table 33. North America Venous Thromboembolism (VTE) Devices Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Venous Thromboembolism (VTE) Devices Sales in Volume by Region (2017-2028) & (K Units) Table 35. Asia Pacific Venous Thromboembolism (VTE) Devices Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Venous Thromboembolism (VTE) Devices Sales in Volume by Country (2017-2028) & (K Units) Table 37. Europe Venous Thromboembolism (VTE) Devices Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Venous Thromboembolism (VTE) Devices Sales in Volume by Country (2017-2028) & (K Units) Table 39. Latin Americaa Venous Thromboembolism (VTE) Devices Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Venous Thromboembolism (VTE) Devices Sales in Volume by Country (2017-2028) & (K Units) Table 41. Middle East and Africa Venous Thromboembolism (VTE) Devices Sales in Value by Country (2017-2028) & (US$ Million) Table 42. ArjoHuntleigh Corporation Information Table 43. ArjoHuntleigh Description and Business Overview Table 44. ArjoHuntleigh Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 45. ArjoHuntleigh Venous Thromboembolism (VTE) Devices Product Table 46. ArjoHuntleigh Recent Development Table 47. Armetheon Corporation Information Table 48. Armetheon Description and Business Overview Table 49. Armetheon Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 50. Armetheon Product Table 51. Armetheon Recent Development Table 52. Bayer Corporation Information Table 53. Bayer Description and Business Overview Table 54. Bayer Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 55. Bayer Product Table 56. Bayer Recent Development Table 57. Bio Compression Systems Corporation Information Table 58. Bio Compression Systems Description and Business Overview Table 59. Bio Compression Systems Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 60. Bio Compression Systems Product Table 61. Bio Compression Systems Recent Development Table 62. Boehringer Ingelheim Corporation Information Table 63. Boehringer Ingelheim Description and Business Overview Table 64. Boehringer Ingelheim Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 65. Boehringer Ingelheim Product Table 66. Boehringer Ingelheim Recent Development Table 67. Breg Corporation Information Table 68. Breg Description and Business Overview Table 69. Breg Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 70. Breg Product Table 71. Breg Recent Development Table 72. Bristol-Myers Squibb Corporation Information Table 73. Bristol-Myers Squibb Description and Business Overview Table 74. Bristol-Myers Squibb Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 75. Bristol-Myers Squibb Product Table 76. Bristol-Myers Squibb Recent Development Table 77. Cardinal Health Corporation Information Table 78. Cardinal Health Description and Business Overview Table 79. Cardinal Health Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 80. Cardinal Health Product Table 81. Cardinal Health Recent Development Table 82. Currie Medical Specialties Corporation Information Table 83. Currie Medical Specialties Description and Business Overview Table 84. Currie Medical Specialties Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 85. Currie Medical Specialties Product Table 86. Currie Medical Specialties Recent Development Table 87. Daiichi-Sankyo Corporation Information Table 88. Daiichi-Sankyo Description and Business Overview Table 89. Daiichi-Sankyo Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 90. Daiichi-Sankyo Product Table 91. Daiichi-Sankyo Recent Development Table 92. Devon Medical Products Corporation Information Table 93. Devon Medical Products Description and Business Overview Table 94. Devon Medical Products Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 95. Devon Medical Products Product Table 96. Devon Medical Products Recent Development Table 97. DJO Corporation Information Table 98. DJO Description and Business Overview Table 99. DJO Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 100. DJO Product Table 101. DJO Recent Development Table 102. Janssen Corporation Information Table 103. Janssen Description and Business Overview Table 104. Janssen Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 105. Janssen Product Table 106. Janssen Recent Development Table 107. Mego Afek AC LTD Corporation Information Table 108. Mego Afek AC LTD Description and Business Overview Table 109. Mego Afek AC LTD Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 110. Mego Afek AC LTD Product Table 111. Mego Afek AC LTD Recent Development Table 112. Normatec Corporation Information Table 113. Normatec Description and Business Overview Table 114. Normatec Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 115. Normatec Product Table 116. Normatec Recent Development Table 117. Pfizer Corporation Information Table 118. Pfizer Description and Business Overview Table 119. Pfizer Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 120. Pfizer Product Table 121. Pfizer Recent Development Table 122. Portola Pharmaceuticals Corporation Information Table 123. Portola Pharmaceuticals Description and Business Overview Table 124. Portola Pharmaceuticals Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 125. Portola Pharmaceuticals Product Table 126. Portola Pharmaceuticals Recent Development Table 127. ThermoTek USA Corporation Information Table 128. ThermoTek USA Description and Business Overview Table 129. ThermoTek USA Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 130. ThermoTek USA Product Table 131. ThermoTek USA Recent Development Table 132. Zimmer Biomet Corporation Information Table 133. Zimmer Biomet Description and Business Overview Table 134. Zimmer Biomet Venous Thromboembolism (VTE) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 135. Zimmer Biomet Product Table 136. Zimmer Biomet Recent Development Table 137. Key Raw Materials Lists Table 138. Raw Materials Key Suppliers Lists Table 139. Venous Thromboembolism (VTE) Devices Customers List Table 140. Venous Thromboembolism (VTE) Devices Distributors List Table 141. Research Programs/Design for This Report Table 142. Key Data Information from Secondary Sources Table 143. Key Data Information from Primary Sources List of Figures Figure 1. Venous Thromboembolism (VTE) Devices Product Picture Figure 2. Global Venous Thromboembolism (VTE) Devices Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Venous Thromboembolism (VTE) Devices Market Size 2017-2028 (US$ Million) Figure 4. Global Venous Thromboembolism (VTE) Devices Sales 2017-2028 (K Units) Figure 5. United States Venous Thromboembolism (VTE) Devices Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Venous Thromboembolism (VTE) Devices Market Size 2017-2028 (US$ Million) Figure 7. United States Venous Thromboembolism (VTE) Devices Sales 2017-2028 (K Units) Figure 8. United States Venous Thromboembolism (VTE) Devices Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Venous Thromboembolism (VTE) Devices Market Share in Global, in Volume (K Units) 2017-2028 Figure 10. Venous Thromboembolism (VTE) Devices Report Years Considered Figure 11. Product Picture of Deep Vein Thrombosis(DVT) Figure 12. Product Picture of Pulmonary Embolism(PE) Figure 13. Product Picture of Others Figure 14. Global Venous Thromboembolism (VTE) Devices Market Share by Type in 2022 & 2028 Figure 15. Global Venous Thromboembolism (VTE) Devices Sales in Value by Type (2017-2028) & (US$ Million) Figure 16. Global Venous Thromboembolism (VTE) Devices Sales Market Share in Value by Type (2017-2028) Figure 17. Global Venous Thromboembolism (VTE) Devices Sales by Type (2017-2028) & (K Units) Figure 18. Global Venous Thromboembolism (VTE) Devices Sales Market Share in Volume by Type (2017-2028) Figure 19. Global Venous Thromboembolism (VTE) Devices Price by Type (2017-2028) & (US$/Unit) Figure 20. United States Venous Thromboembolism (VTE) Devices Market Share by Type in 2022 & 2028 Figure 21. United States Venous Thromboembolism (VTE) Devices Sales in Value by Type (2017-2028) & (US$ Million) Figure 22. United States Venous Thromboembolism (VTE) Devices Sales Market Share in Value by Type (2017-2028) Figure 23. United States Venous Thromboembolism (VTE) Devices Sales by Type (2017-2028) & (K Units) Figure 24. United States Venous Thromboembolism (VTE) Devices Sales Market Share in Volume by Type (2017-2028) Figure 25. United States Venous Thromboembolism (VTE) Devices Price by Type (2017-2028) & (US$/Unit) Figure 26. Product Picture of Hospitals Figure 27. Product Picture of Surgical Centers Figure 28. Product Picture of Other Figure 29. Global Venous Thromboembolism (VTE) Devices Market Share by Application in 2022 & 2028 Figure 30. Global Venous Thromboembolism (VTE) Devices Sales in Value by Application (2017-2028) & (US$ Million) Figure 31. Global Venous Thromboembolism (VTE) Devices Sales Market Share in Value by Application (2017-2028) Figure 32. Global Venous Thromboembolism (VTE) Devices Sales by Application (2017-2028) & (K Units) Figure 33. Global Venous Thromboembolism (VTE) Devices Sales Market Share in Volume by Application (2017-2028) Figure 34. Global Venous Thromboembolism (VTE) Devices Price by Application (2017-2028) & (US$/Unit) Figure 35. United States Venous Thromboembolism (VTE) Devices Market Share by Application in 2022 & 2028 Figure 36. United States Venous Thromboembolism (VTE) Devices Sales in Value by Application (2017-2028) & (US$ Million) Figure 37. United States Venous Thromboembolism (VTE) Devices Sales Market Share in Value by Application (2017-2028) Figure 38. United States Venous Thromboembolism (VTE) Devices Sales by Application (2017-2028) & (K Units) Figure 39. United States Venous Thromboembolism (VTE) Devices Sales Market Share in Volume by Application (2017-2028) Figure 40. United States Venous Thromboembolism (VTE) Devices Price by Application (2017-2028) & (US$/Unit) Figure 41. North America Venous Thromboembolism (VTE) Devices Sales in Volume Growth Rate 2017-2028 (K Units) Figure 42. North America Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 43. U.S. Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 44. Canada Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 45. Europe Venous Thromboembolism (VTE) Devices Sales in Volume Growth Rate 2017-2028 (K Units) Figure 46. Europe Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 47. Germany Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. France Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. U.K. Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Italy Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Russia Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. Asia-Pacific Venous Thromboembolism (VTE) Devices Sales in Volume Growth Rate 2017-2028 (K Units) Figure 53. Asia-Pacific Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 54. China Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. Japan Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. South Korea Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. India Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Australia Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Taiwan Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Indonesia Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Thailand Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Malaysia Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Philippines Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Latin America Venous Thromboembolism (VTE) Devices Sales in Volume Growth Rate 2017-2028 (K Units) Figure 65. Latin America Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 66. Mexico Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Brazil Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Argentina Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 69. Middle East & Africa Venous Thromboembolism (VTE) Devices Sales in Volume Growth Rate 2017-2028 (K Units) Figure 70. Middle East & Africa Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 71. Turkey Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. Saudi Arabia Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. UAE Venous Thromboembolism (VTE) Devices Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 74. Venous Thromboembolism (VTE) Devices Value Chain Figure 75. Venous Thromboembolism (VTE) Devices Production Process Figure 76. Channels of Distribution Figure 77. Distributors Profiles Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed
ArjoHuntleigh Armetheon Bayer Bio Compression Systems Boehringer Ingelheim Breg Bristol-Myers Squibb Cardinal Health Currie Medical Specialties Daiichi-Sankyo Devon Medical Products DJO Janssen Mego Afek AC LTD Normatec Pfizer Portola Pharmaceuticals ThermoTek USA Zimmer Biomet
Physical Therapy Equipment market is segmented by region (country), players, by Type and by Appli ... Read More
Packaging Plastic Compounding market is segmented by region (country), players, by Type and by Ap ... Read More
Point of Entry Water Filtration Systems market is segmented by region (country), players, by Type ... Read More
Heavy-Duty Gas Turbine Services market is segmented by region (country), players, by Type and by ... Read More